Bogle Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bogle Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-31,851	Closed	-$1.79M	–	383
2017 Q2	$1.79M	Sell	31,851 -298,467	-90%	-$12M	0.13%	156
2017 Q1	$12.9M	Buy	+330,318	New	+$10.5M	0.9%	29
2014 Q1	–	Sell	-148,483	Closed	-$3.82M	–	423
2013 Q4	$3.82M	Buy	+148,483	New	+$3.61M	0.32%	109

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bogle Investment Management's PTLA Position: Q3 2017 in Review

Bogle Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2017, closing a stake of 31,851 shares — an estimated $1.79M sold.

Bogle Investment Management first reported a position in PTLA in Q4 2013 and held it in 3 quarters. The position peaked at $12.9M in Q1 2017. 221 funds tracked by Wall St. Rank hold PTLA as of Q3 2017.

Bogle Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Bogle Investment Management sold 31,851 Portola Pharmaceuticals, Inc. shares in Q3 2017, an estimated $1.79M.
Bogle Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 3 quarters.
Bogle Investment Management's Portola Pharmaceuticals, Inc. position peaked at $12.9M in Q1 2017.
221 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2017.

Based on Bogle Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.